Characterising the Metabolomic Diversity and Biological Potentials of Extracts from Different Parts of Two Cistus Species Using UHPLC-MS/MS and In Vitro Techniques
View/ Open
Access
info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/3.0/us/Date
2024Author
Ahmed, ShakeelSelvi, Selami
Ak, Güneş
Cziáky, Zoltán
Jek, József
Rodrigues, Maria J.
Custodio, Luisa
Zengin, Gökhan
Metadata
Show full item recordAbstract
This study investigates the biochemical composition and biological properties of different
parts (leaves, roots, and twigs) of two Cistus species (Cistus monspeliasis and Cistus parviflorus). The
extracts were analysed using UHPLC-MS/MS to determine their chemical profiling. A range of
antioxidant assays were performed to evaluate the extract’s antioxidant capabilities. The enzyme
inhibition studies focused on acetylcholinesterase (AChE), butyrylcholinesterase (BChE), α-amylase,
and α-glucosidase and tyrosinase. In addition, the study examined the antimicrobial effects on
different bacteria and yeasts and evaluated the toxicity using the MTT assay. Quinic acid, citric
acid, gallic acid, catechin, quercetin derivatives, kaempferol, myricetin, ellagic acid, prodelphinidins, procyanidins, scopoletin, and flavogallonic acid dilactone are the main bioactive compounds
found in both species. In enzyme inhibition assays, C. monspeliasis roots exhibited significant activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), with the values of
2.58 ± 0.02 mg GALAE/g and 11.37 ± 1.93 mg GALAE/g, respectively. Cytotoxicity studies showed
mostly weak toxicity, with some samples moderately reducing viability in RAW and HepG2 cells.
These findings underscore the diverse biochemical profiles and bioactive potential of Cistus species,
suggesting their utility as natural sources of antioxidants and enzyme inhibitors for pharmaceutical
and nutraceutical development.
Source
PathogensVolume
13Issue
9Collections
The following license files are associated with this item: